Text Size

Vaginal Microbiota Among Postmenopausal Women

This study has been completed.
Sponsor:
Information provided by:
Lawson Health Research Institute
ClinicalTrials.gov Identifier:
NCT01084616
First received: March 9, 2010
Last updated: December 16, 2010
Last verified: December 2010
History of Changes

March 9, 2010
December 16, 2010
January 2010
July 2010   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01084616 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Vaginal Microbiota Among Postmenopausal Women
The Role of Vaginal Microbiota in Symptoms of Vaginal Dryness in Postmenopausal Women

It is known that vaginal bacteria have an impact upon the health status of the host, in some cases protecting against infection and in other cases causing infection, depending on the bacterial types present. This study will compare the composition of vaginal bacteria to symptoms of vaginal dryness in order to try and identify if certain bacteria might cause some of the problems associated with vaginal dryness among post-menopausal women.
Not Provided
Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample

Postmenopausal women
Vulvovaginal Atrophy
Not Provided
  • Vaginal Dryness
  • Non-vaginal dryness
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
16
July 2010
July 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Between 30 and 80 years old.
  • Postmenopausal = 12 months of spontaneous amenorrhea or 6 months of spontaneous amenorrhea with serum FSH levels > 40 mIU/ml or 6 weeks postsurgical bilateral oophorectomy with or without hysterectomy.
  • Prepared not to take hormone replacement therapy during 8 weeks follow-up and not taking estrogen alone or estrogen/progestin containing drug products at the time of screening.
Female
30 Years to 80 Years
No
Contact information is only displayed when the study is recruiting subjects
Canada
 
NCT01084616
R-09-804, 16182E
No
Dr. Gregor Reid, Lawson Health Research Institute
Lawson Health Research Institute
Not Provided
Principal Investigator: Gregor Reid, PhD Lawson Health Research Institute
Lawson Health Research Institute
December 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP